Loading...
Loading...
Browse all stories on DeepNewz
VisitQuanterix to Acquire Akoya Biosciences in All-Stock Deal for First Integrated Solution in Ultra-Sensitive Biomarker Detection
Jan 10, 2025, 11:37 AM
Quanterix Corporation has reached an agreement to acquire Akoya Biosciences in an all-stock transaction. This merger aims to create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers, enhancing capabilities in disease detection at various stages. Both companies are recognized for their contributions to life sciences, with Quanterix focusing on advanced biomarker detection technologies and Akoya specializing in spatial biology solutions. The deal is expected to combine their strengths and improve diagnostic capabilities in the healthcare sector.
View original story
Markets
No • 50%
Yes • 50%
Official announcements from Quanterix or Akoya Biosciences, or product launch events
Yes • 50%
No • 50%
Official press releases from Quanterix or Akoya Biosciences, or financial news outlets
No • 50%
Yes • 50%
Regulatory filings or announcements from relevant financial authorities
2-3 • 25%
4 or more • 25%
0 • 25%
1 • 25%
Official product announcements or company reports
Increase by less than 10% • 25%
Increase by more than 30% • 25%
Decrease • 25%
Increase by 10-30% • 25%
Quanterix's fiscal year 2025 financial report
Decrease • 25%
Increase by more than 20% • 25%
Increase by 10-20% • 25%
Increase by less than 10% • 25%
Stock market data and financial reports